Cipla Limited is an Indian multinational pharmaceutical company that is headquartered in Mumbai, Maharashtra. The company is primarily known for producing generic drugs for various therapeutic uses.

Cipla's total research and development expenditure for the quarter reached ₹385 Crore, representing 5.5% of total sales and reflecting a 2% increase year-on-year.

The Capital Structure page of Cipla Ltd. presents the Authorized Capital, Issued Capital, and Paid-Up Equity Capital of the company over the period.